Title: Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice

Journal Article · · Frontiers in Pharmacology
 [1];  [2];  [2];  [2];  [2];  [2];  [2];  [2];  [2];  [2];  [3];  [3];  [4];  [2];  [2]
  1. The Second Affiliated Hospital of Nanjing Medical Univ., Nanjing (China). Dept. of Endocrinology; OSTI
  2. The Second Affiliated Hospital of Nanjing Medical Univ., Nanjing (China). Dept. of Endocrinology
  3. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Biological Systems and Engineering Division
  4. Nanjing Medical Univ., Nanjing (China). Key Lab. of Pathogen of Jiangsu Province. Department of Pathogen Biology-Microbiology Division

Oral administration of resveratrol is able to ameliorate the progression of diabetic nephropathy (DN); however, its mechanisms of action remain unclear. Recent evidence suggested that the gut microbiota is involved in the metabolism therapeutics. In the current study, we sought to determine whether the anti-DN effects of resveratrol are mediated through modulation of the gut microbiota using the genetic db/db mouse model of DN. We demonstrate that resveratrol treatment of db/db mice relieves a series of clinical indicators of DN. We then show that resveratrol improves intestinal barrier function and ameliorates intestinal permeability and inflammation. The composition of the gut microbiome was significantly altered in db/db mice compared to control db/m mice. Dysbiosis in db/db mice characterized by low abundance levels of Bacteroides, Alistipes, Rikenella, Odoribacter, Parabacteroides, and Alloprevotella genera were reversed by resveratrol treatment, suggesting a potential role for the microbiome in DN progression. Furthermore, fecal microbiota transplantation, derived from healthy resveratrol-treated db/m mice, was sufficient to antagonize the renal dysfunction, rebalance the gut microbiome and improve intestinal permeability and inflammation in recipient db/db mice. These results indicate that resveratrol-mediated changes in the gut microbiome may play an important role in the mechanism of action of resveratrol, which provides supporting evidence for the gut–kidney axis in DN.

Research Organization:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1816093
Journal Information:
Frontiers in Pharmacology, Journal Name: Frontiers in Pharmacology Vol. 11; ISSN 1663-9812
Publisher:
Frontiers Research FoundationCopyright Statement
Country of Publication:
United States
Language:
English

References (39)

The Microbiome and Risk for Obesity and Diabetes journal January 2017
Metabolism and bioavailability oftrans-resveratrol journal May 2005
The gut–kidney axis journal November 2016
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease journal March 2017
Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins journal September 2018
The role of the intestinal microbiota in uremic solute accumulation: a focus on sulfur compounds journal January 2019
Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signaling journal July 2011
The impact of gut microbiota on kidney function and pathogenesis journal September 2017
Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota journal June 2012
Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction journal April 2017
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential journal March 2019
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects journal October 2016
Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats journal June 2015
Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update journal April 2013
Resveratrol and inflammatory bowel disease: the evidence so far journal December 2017
Protective Capacity of Resveratrol, a Natural Polyphenolic Compound, against Deoxynivalenol-Induced Intestinal Barrier Dysfunction and Bacterial Translocation journal April 2016
Resveratrol improves health and survival of mice on a high-calorie diet journal November 2006
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 journal October 2009
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy journal May 2011
Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice journal February 2019
The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease journal May 2018
Immunity, microbiota and kidney disease journal February 2019
Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy journal April 2017
Resveratrol, in its natural combination in whole grape, for health promotion and disease management: Grape in health promotion and disease management journal June 2015
Resveratrol Attenuates Trimethylamine- N -Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota journal May 2016
Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis journal July 2018
Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice journal October 2018
Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure journal April 2017
Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK journal January 2010
Resveratrol Alleviates Inflammatory Responses and Oxidative Stress in Rat Kidney Ischemia-Reperfusion Injury and H2O2-Induced NRK-52E Cells via the Nrf2/TLR4/NF-κB Pathway journal January 2018
Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy journal October 2016
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults journal February 2010
Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD–Related Systemic Inflammation journal May 2016
Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome journal November 2016
Beneficial effects of Bacteroides fragilis polysaccharides on the immune system journal January 2010
Resveratrol, Metabolic Syndrome, and Gut Microbiota journal November 2018
Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota journal November 2017
Role of commensal gut bacteria in inflammatory bowel diseases journal November 2012
Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults journal January 2011